← Open Payments lookup

KATHLEEN MICIANO: Open Payments

NPI 1477110260 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$280 in 13 payments from 8 companies in 2025. Trend: 2023 $200 · 2024 $0 · 2025 $280

Food & beverage: $280
CompanyPaymentsAmount
Axsome Therapeutics, Inc.3$64
Novo Nordisk Inc2$45
Sumitomo Pharma America, Inc.2$37
AstraZeneca Pharmaceuticals LP2$34
ABBVIE INC.1$30
Novartis Pharmaceuticals Corporation1$29
Otsuka America Pharmaceutical, Inc.1$24
TOLMAR, INC.1$18

Products named: Symbravo, GEMTESA, AIRSUPRA, QULIPTA, LEQVIO, Wegovy, REXULTI, Ozempic.

Industry payments across TX — which companies pay providers there.